Healthcare provider profile · identity verified

Abdel Roberto Marques, MD

Internal Medicine · PARKER, CO · NPI 1649709890

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	885	90
Atorvastatin Calcium	Atorvastatin Calcium	716	124
Furosemide	Furosemide	491	95
Levothyroxine Sodium	Levothyroxine Sodium	434	78
Tamsulosin Hcl	Tamsulosin Hcl	351	59
Amlodipine Besylate	Amlodipine Besylate	342	66
Trazodone Hcl	Trazodone Hcl	339	53
Sertraline Hcl	Sertraline Hcl	328	52
Potassium Chloride	Potassium Chloride	327	56
Gabapentin	Gabapentin	319	70
Myrbetriq	Mirabegron	281	21
Losartan Potassium	Losartan Potassium	256	43
Lisinopril	Lisinopril	238	45
Pantoprazole Sodium	Pantoprazole Sodium	215	46
Metoprolol Succinate	Metoprolol Succinate	200	43
Xarelto	Rivaroxaban	188	16
Carvedilol	Carvedilol	184	27
Duloxetine Hcl	Duloxetine Hcl	175	41
Ondansetron Hcl	Ondansetron Hcl	159	63
Finasteride	Finasteride	151	21
Metoprolol Tartrate	Metoprolol Tartrate	136	27
Risperidone	Risperidone	136	25
Escitalopram Oxalate	Escitalopram Oxalate	130	26
Metformin Hcl	Metformin Hcl	123	29
Diclofenac Sodium	Diclofenac Sodium	120	31
Spironolactone	Spironolactone	113	21
Clopidogrel	Clopidogrel Bisulfate	111	19
Venlafaxine Hcl Er	Venlafaxine Hcl	105	17
Mirtazapine	Mirtazapine	104	26
Quetiapine Fumarate	Quetiapine Fumarate	102	23
Latanoprost	Latanoprost	101	18
Donepezil Hcl	Donepezil Hcl	99	27
Memantine Hcl	Memantine Hcl	96	13
Prednisone	Prednisone	93	44
Rosuvastatin Calcium	Rosuvastatin Calcium	92	15
Methocarbamol	Methocarbamol	88	30
Citalopram Hbr	Citalopram Hydrobromide	86	14
Carbidopa-Levodopa	Carbidopa/Levodopa	84	13
Baclofen	Baclofen	83	15
Warfarin Sodium	Warfarin Sodium	82	suppressed
Lamotrigine	Lamotrigine	79	suppressed
Jardiance	Empagliflozin	76	suppressed
Klor-Con 10	Potassium Chloride	74	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	71	35
Allopurinol	Allopurinol	70	13
Fluticasone Propionate	Fluticasone Propionate	69	24
Celecoxib	Celecoxib	67	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	67	19
Levetiracetam	Levetiracetam	66	12
Buspirone Hcl	Buspirone Hcl	62	11
Famotidine	Famotidine	62	24
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	60	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	14
Lactulose	Lactulose	58	12
Montelukast Sodium	Montelukast Sodium	57	14
Aripiprazole	Aripiprazole	56	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	55	31
Olanzapine	Olanzapine	55	14
Bumetanide	Bumetanide	54	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	12
Alendronate Sodium	Alendronate Sodium	53	suppressed
Trulicity	Dulaglutide	53	suppressed
Torsemide	Torsemide	52	11
Acetic Acid	Acetic Acid	51	suppressed
Tramadol Hcl	Tramadol Hcl	51	19
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	50	suppressed
Nystatin	Nystatin	50	28
Ondansetron Odt	Ondansetron	50	15
Rytary	Carbidopa/Levodopa	50	suppressed
Azithromycin	Azithromycin	48	21
Oxybutynin Chloride	Oxybutynin Chloride	48	suppressed
Entresto	Sacubitril/Valsartan	47	suppressed
Timolol Maleate	Timolol Maleate	47	suppressed
Farxiga	Dapagliflozin Propanediol	45	suppressed
Sodium Chloride	0.9 % Sodium Chloride	45	31
Ursodiol	Ursodiol	45	suppressed
Pregabalin	Pregabalin	44	13
Propranolol Hcl	Propranolol Hcl	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Amiodarone Hcl	Amiodarone Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Omeprazole	Omeprazole	37	20
Dicyclomine Hcl	Dicyclomine Hcl	36	suppressed
Erythromycin	Erythromycin Base	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	36	19
Hydrochlorothiazide	Hydrochlorothiazide	35	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Topiramate	Topiramate	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	16
Wixela Inhub	Fluticasone Propion/Salmeterol	33	suppressed
Mirabegron Er	Mirabegron	31	16
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Vraylar	Cariprazine Hcl	31	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	30	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Clozapine	Clozapine	30	suppressed
Midodrine Hcl	Midodrine Hcl	30	14
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	30	14
Albuterol Sulfate	Albuterol Sulfate	29	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	23
Divalproex Sodium	Divalproex Sodium	28	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	11
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Ozempic	Semaglutide	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	14
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Levofloxacin	Levofloxacin	26	16
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	26	suppressed
Cephalexin	Cephalexin	25	17
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Methimazole	Methimazole	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	23	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	23	suppressed
Primidone	Primidone	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Carbamazepine	Carbamazepine	22	suppressed
Meloxicam	Meloxicam	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	12
Simvastatin	Simvastatin	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Lithium Carbonate Er	Lithium Carbonate	21	suppressed
Risperdal Consta	Risperidone Microspheres	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	20	suppressed
Ketoconazole	Ketoconazole	20	11
Olanzapine Odt	Olanzapine	20	suppressed
Ceftriaxone	Ceftriaxone Sodium	19	15
Cinacalcet Hcl	Cinacalcet Hcl	19	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Megestrol Acetate	Megestrol Acetate	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Prednisolone Acetate	Prednisolone Acetate	18	suppressed
Atenolol	Atenolol	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Estradiol	Estradiol	17	suppressed
Gemtesa	Vibegron	17	suppressed
Granisetron Hcl	Granisetron Hcl	17	suppressed
Methenamine Hippurate	Methenamine Hippurate	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Motegrity	Prucalopride Succinate	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Ceftriaxone	Ceftriaxone In Is-Osm Dextrose	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Leflunomide	Leflunomide	13	suppressed
Letrozole	Letrozole	13	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nyamyc	Nystatin	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Glipizide	Glipizide	12	suppressed
Lidocaine Hcl	Lidocaine Hcl	12	11
Miebo	Perfluorohexyloctane/Pf	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Dalfampridine Er	Dalfampridine	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Haloperidol Lactate	Haloperidol Lactate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error